Browse the corpus

Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.

1 passage

contentuptodate· Content· item f6_63_7166

©2013 UpToDate ® Print Email Choice of antihypertensive monotherapy does not predict outcome In the ALLHAT trial, cumulative event rates for the primary outcome (fatal coronary heart disease or nonfatal myocardial infarction) according to primary treatment with chlorthalidone, amlodipine, or lisinopril. Compared to chlorthalidone, there was no significant difference with amiodipine (relative risk 0.98) or lisinopril (relative risk 0.99 percent) at a mean of 4.9 years. Data from The ALLHAT Officers, JAMA 2002; 288:2981.